Mediation of the Cardioprotective Effects of Mannitol Discovered, with Refutation of Common Protein Kinases

Int J Mol Sci. 2021 Nov 19;22(22):12471. doi: 10.3390/ijms222212471.

Abstract

The osmodiuretic agent Mannitol exerts cardioprotection against ischemia and reperfusion (I/R) injury when applied as a pre- and/or postconditioning stimulus. Previously, we demonstrated that these properties are mediated via the activation of mitochondrial ATP-sensitive potassium (mKATP) channels. However, considering Mannitol remains in the extracellular compartment, the question arises as to which receptor and intracellular signaling cascades are involved in myocardial protection by the osmodiuretic substance. Protein kinase B (Akt) and G (PKG), as part of the reperfusion injury salvage kinase (RISK) and/or endothelial nitric oxide (eNOS)/PKG pathway, are two well-investigated intracellular targets conferring myocardial protection upstream of mitochondrial potassium channels. Adenosine receptor subtypes have been shown to trigger different cardioprotective pathways, for example, the reperfusion injury. Further, Mannitol induces an increased activation of the adenosine 1 receptor (A1R) in renal cells conferring its nephroprotective properties. Therefore, we investigated whether (1) Akt and PKG are possible signaling targets involved in Mannitol-induced conditioning upstream of the mKATP channel and/or whether (2) cardioprotection by Mannitol is mediated via activation of the A1R. All experiments were performed on male Wistar rats in vitro employing the Langendorff isolated heart perfusion technique with infarct size determination as the primary endpoint. To unravel possible protein kinase activation, Mannitol was applied in combination with the Akt (MK2206) or PKG (KT5823) inhibitor. In further groups, an A1R blocker (DPCPX) was given with or without Mannitol. Preconditioning with Mannitol (Man) significantly reduced the infarct size compared to the control group. Co-administration of the A1R blocker DPXPC fully abolished myocardial protection of Mannitol. Interestingly and in contrast to the initial hypothesis, neither administration of the Akt nor the PKG blocker had any impact on the cardioprotective properties of Mannitol-induced preconditioning. These results are quite unexpected and show that the protein kinases Akt and PKG-as possible targets of known protective signaling cascades-are not involved in Mannitol-induced preconditioning. However, the cardioprotective effects of Mannitol are mediated via the A1R.

Keywords: adenosine receptor; mannitol; myocardial infarction; preconditioning; protein kinase B; protein kinase G.

MeSH terms

  • Animals
  • Carbazoles / pharmacology
  • Cyclic GMP-Dependent Protein Kinases / antagonists & inhibitors
  • Cyclic GMP-Dependent Protein Kinases / genetics*
  • Heart / drug effects
  • Heart / physiopathology
  • Heterocyclic Compounds, 3-Ring / pharmacology
  • Humans
  • Ischemic Preconditioning, Myocardial
  • KATP Channels / antagonists & inhibitors
  • Kidney / drug effects
  • Kidney / pathology
  • Mannitol / pharmacology*
  • Myocardial Reperfusion Injury / drug therapy
  • Myocardial Reperfusion Injury / genetics
  • Myocardial Reperfusion Injury / pathology
  • Myocardium / metabolism
  • Myocardium / pathology
  • Nitric Oxide Synthase Type III / genetics
  • Proto-Oncogene Proteins c-akt / antagonists & inhibitors
  • Proto-Oncogene Proteins c-akt / genetics*
  • Rats
  • Receptor, Adenosine A1 / drug effects
  • Receptor, Adenosine A1 / genetics*
  • Reperfusion Injury / drug therapy*
  • Reperfusion Injury / genetics
  • Reperfusion Injury / pathology
  • Signal Transduction / drug effects
  • Xanthines / pharmacology

Substances

  • Carbazoles
  • Heterocyclic Compounds, 3-Ring
  • KATP Channels
  • MK 2206
  • Receptor, Adenosine A1
  • Xanthines
  • KT 5823
  • Mannitol
  • 1,3-dipropyl-8-cyclopentylxanthine
  • Nitric Oxide Synthase Type III
  • Nos3 protein, rat
  • Akt1 protein, rat
  • Proto-Oncogene Proteins c-akt
  • Cyclic GMP-Dependent Protein Kinases